Juha Partanen - Publications

Affiliations: 
University of Helsinki, Helsingfors, Finland 

69/139 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Partanen J, Achim K. Neurons gating behavior-developmental, molecular and functional features of neurons in the Substantia Nigra pars reticulata. Frontiers in Neuroscience. 16: 976209. PMID 36148148 DOI: 10.3389/fnins.2022.976209  0.343
2022 Kirjavainen A, Singh P, Lahti L, Seja P, Lelkes Z, Makkonen A, Kilpinen S, Ono Y, Salminen M, Aitta-Aho T, Stenberg T, Molchanova S, Achim K, Partanen J. Gata2, Nkx2-2 and Skor2 form a transcription factor network regulating development of a midbrain GABAergic neuron subtype with characteristics of REM-sleep regulatory neurons. Development (Cambridge, England). 149. PMID 35815619 DOI: 10.1242/dev.200937  0.329
2020 Morello F, Borshagovski D, Survila M, Tikker L, Sadik-Ogli S, Kirjavainen A, Estartús N, Knaapi L, Lahti L, Törönen P, Mazutis L, Delogu A, Salminen M, Achim K, Partanen J. Molecular Fingerprint and Developmental Regulation of the Tegmental GABAergic and Glutamatergic Neurons Derived from the Anterior Hindbrain. Cell Reports. 33: 108268. PMID 33053343 DOI: 10.1016/j.celrep.2020.108268  0.707
2020 Tikker L, Casarotto P, Singh P, Biojone C, Piepponen P, Estartús N, Seelbach A, Sridharan R, Laukkanen L, Castrén E, Partanen J. Inactivation of the GATA cofactor ZFPM1 results in abnormal development of dorsal raphe serotonergic neuron subtypes and increased anxiety-like behaviour. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33046550 DOI: 10.1523/JNEUROSCI.2252-19.2020  0.321
2019 Mennesson M, Rydgren E, Lipina T, Sokolowska E, Kulesskaya N, Morello F, Ivakine E, Voikar V, Risbrough V, Partanen J, Hovatta I. Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30770891 DOI: 10.1038/S41386-019-0344-5  0.335
2019 Brodski C, Blaess S, Partanen J, Prakash N. Crosstalk of Intercellular Signaling Pathways in the Generation of Midbrain Dopaminergic Neurons In Vivo and from Stem Cells. Journal of Developmental Biology. 7. PMID 30650592 DOI: 10.3390/jdb7010003  0.363
2017 Zega K, Jovanovic VM, Vitic Z, Niedzielska M, Knaapi L, Jukic MM, Partanen J, Friedel RF, Lang R, Brodski C. Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool. Frontiers in Molecular Neuroscience. 10: 372. PMID 29170629 DOI: 10.3389/Fnmol.2017.00372  0.381
2017 Nikkanen J, Landoni JC, Balboa D, Haugas M, Partanen J, Paetau A, Isohanni P, Brilhante V, Suomalainen A. A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions. Embo Molecular Medicine. PMID 29109127 DOI: 10.15252/Emmm.201707993  0.334
2017 Rice R, Cebra-Thomas J, Haugas M, Partanen J, Rice DPC, Gilbert SF. Melanoblast development coincides with the late emerging cells from the dorsal neural tube in turtle Trachemys scripta. Scientific Reports. 7: 12063. PMID 28935865 DOI: 10.1038/S41598-017-12352-0  0.323
2016 Jager P, Ye Z, Yu X, Zagoraiou L, Prekop HT, Partanen J, Jessell TM, Wisden W, Brickley SG, Delogu A. Tectal-derived interneurons contribute to phasic and tonic inhibition in the visual thalamus. Nature Communications. 7: 13579. PMID 27929058 DOI: 10.1038/Ncomms13579  0.691
2016 Haugas M, Tikker L, Achim K, Salminen M, Partanen J. Gata2 and Gata3 regulate the differentiation of serotonergic and glutamatergic neuron subtypes of the dorsal raphe. Development (Cambridge, England). 143: 4495-4508. PMID 27789623 DOI: 10.1242/dev.136614  0.37
2015 Lahti L, Haugas M, Tikker L, Airavaara M, Voutilainen MH, Anttila J, Kumar S, Inkinen C, Salminen M, Partanen J. Differentiation and molecular heterogeneity of inhibitory and excitatory neurons associated with midbrain dopaminergic nuclei. Development (Cambridge, England). PMID 26718003 DOI: 10.1242/Dev.129957  0.458
2015 Morello F, Partanen J. Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nuclei. Febs Letters. 589: 3693-701. PMID 26453835 DOI: 10.1016/J.Febslet.2015.10.001  0.43
2014 Achim K, Salminen M, Partanen J. Mechanisms regulating GABAergic neuron development. Cellular and Molecular Life Sciences : Cmls. 71: 1395-415. PMID 24196748 DOI: 10.1007/S00018-013-1501-3  0.457
2013 Achim K, Peltopuro P, Lahti L, Tsai HH, Zachariah A, Astrand M, Salminen M, Rowitch D, Partanen J. The role of Tal2 and Tal1 in the differentiation of midbrain GABAergic neuron precursors. Biology Open. 2: 990-7. PMID 24167708 DOI: 10.1242/Bio.20135041  0.474
2013 Lahti L, Achim K, Partanen J. Molecular regulation of GABAergic neuron differentiation and diversity in the developing midbrain. Acta Physiologica. 207: 616-627. PMID 23297792 DOI: 10.1111/Apha.12062  0.453
2012 Virolainen SM, Achim K, Peltopuro P, Salminen M, Partanen J. Transcriptional regulatory mechanisms underlying the GABAergic neuron fate in different diencephalic prosomeres. Development (Cambridge, England). 139: 3795-805. PMID 22991444 DOI: 10.1242/Dev.075192  0.47
2012 Crespo-Enriquez I, Partanen J, Martinez S, Echevarria D. Fgf8-related secondary organizers exert different polarizing planar instructions along the mouse anterior neural tube. Plos One. 7: e39977. PMID 22792203 DOI: 10.1371/Journal.Pone.0039977  0.347
2012 Achim K, Peltopuro P, Lahti L, Li J, Salminen M, Partanen J. Distinct developmental origins and regulatory mechanisms for GABAergic neurons associated with dopaminergic nuclei in the ventral mesodiencephalic region. Development (Cambridge, England). 139: 2360-70. PMID 22627282 DOI: 10.1242/Dev.076380  0.453
2012 Lahti L, Peltopuro P, Piepponen TP, Partanen J. Cell-autonomous FGF signaling regulates anteroposterior patterning and neuronal differentiation in the mesodiencephalic dopaminergic progenitor domain. Development (Cambridge, England). 139: 894-905. PMID 22278924 DOI: 10.1242/Dev.071936  0.455
2011 Saarimäki-Vire J, Alitalo A, Partanen J. Analysis of Cdh22 expression and function in the developing mouse brain. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 240: 1989-2001. PMID 21761482 DOI: 10.1002/Dvdy.22686  0.355
2011 Lahti L, Saarimäki-Vire J, Rita H, Partanen J. FGF signaling gradient maintains symmetrical proliferative divisions of midbrain neuronal progenitors. Developmental Biology. 349: 270-82. PMID 21074523 DOI: 10.1016/J.Ydbio.2010.11.008  0.497
2011 Lahti L, Saarimäki-Vire J, Rita H, Partanen J. CorrigendumCorrigendum to “FGF signaling gradient maintains symmetrical proliferative divisions of midbrain neuronal progenitors” [Dev. Biol. 349 (2011) 270–282] Developmental Biology. 356: 608. DOI: 10.1016/J.Ydbio.2011.06.023  0.397
2010 Chilov D, Sinjushina N, Saarimäki-Vire J, Taketo MM, Partanen J. beta-Catenin regulates intercellular signalling networks and cell-type specific transcription in the developing mouse midbrain-rhombomere 1 region. Plos One. 5: e10881. PMID 20532162 DOI: 10.1371/Journal.Pone.0010881  0.354
2010 Peltopuro P, Kala K, Partanen J. Distinct requirements for Ascl1 in subpopulations of midbrain GABAergic neurons. Developmental Biology. 343: 63-70. PMID 20417196 DOI: 10.1016/J.Ydbio.2010.04.015  0.425
2010 Yang J, Meyer M, Müller AK, Böhm F, Grose R, Dauwalder T, Verrey F, Kopf M, Partanen J, Bloch W, Ornitz DM, Werner S. Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis. The Journal of Cell Biology. 188: 935-52. PMID 20308431 DOI: 10.1083/Jcb.200910126  0.324
2010 Peltopuro P, Kala K, Partanen J. [P1.29]Distinct requirements for Ascl1 in subpopulations of midbrain GABAergic neurons International Journal of Developmental Neuroscience. 28: 665. DOI: 10.1016/J.Ijdevneu.2010.07.070  0.395
2009 Kala K, Haugas M, Lilleväli K, Guimera J, Wurst W, Salminen M, Partanen J. Gata2 is a tissue-specific post-mitotic selector gene for midbrain GABAergic neurons. Development (Cambridge, England). 136: 253-62. PMID 19088086 DOI: 10.1242/Dev.029900  0.488
2009 Peltopuro P, Kala K, Guillemot F, Partanen J. 21-P025 Transcriptional regulation of GABAergic neuron development in the developing midbrain Mechanisms of Development. 126: S320-S321. DOI: 10.1016/J.Mod.2009.06.890  0.424
2009 Lahti L, Saarimäki-Vire J, Rita H, Partanen J. 21-P010 FGF-signaling in the neurogenesis of the developing midbrain–hindbrain region Mechanisms of Development. 126. DOI: 10.1016/J.Mod.2009.06.875  0.323
2009 Saarimäki-Vire J, Partanen J. 21-P004 Regulation of cell adhesive properties and midbrain-rhombomere1 boundary by a FGF regulated molecule PB-cadherin Mechanisms of Development. 126. DOI: 10.1016/J.Mod.2009.06.869  0.327
2009 Kala K, Haugas M, Lilleväli K, Guimera J, Wurst W, Salminen M, Partanen J. 12-P003 Gata2 is a postmitotic selector gene for GABAergic neurons in the midbrain Mechanisms of Development. 126. DOI: 10.1016/J.Mod.2009.06.457  0.393
2009 Goetz R, Driller K, Mustonen T, Preca T, Partanen J, Neubüser A. 09-P087 FGF signaling is required for the specification of GnRH neurons Mechanisms of Development. 126. DOI: 10.1016/J.Mod.2009.06.417  0.413
2008 Wasteson P, Johansson BR, Jukkola T, Breuer S, Akyürek LM, Partanen J, Lindahl P. Developmental origin of smooth muscle cells in the descending aorta in mice. Development (Cambridge, England). 135: 1823-32. PMID 18417617 DOI: 10.1242/Dev.020958  0.357
2008 Kala K, Jukkola T, Pata I, Partanen J. Analysis of the midbrain-hindbrain boundary cell fate using a boundary cell-specific Cre-mouse strain. Genesis (New York, N.Y. : 2000). 46: 29-36. PMID 18196597 DOI: 10.1002/Dvg.20344  0.375
2008 Kala K, Haugas M, Lilleväli K, Salminen M, Partanen J. The role of Gata2 in the midbrain GABAergic neuron development International Journal of Developmental Neuroscience. 26: 851. DOI: 10.1016/J.Ijdevneu.2008.09.080  0.427
2007 Saarimäki-Vire J, Peltopuro P, Lahti L, Naserke T, Blak AA, Vogt Weisenhorn DM, Yu K, Ornitz DM, Wurst W, Partanen J. Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 8581-92. PMID 17687036 DOI: 10.1523/Jneurosci.0192-07.2007  0.511
2007 Zhang FP, Domanskyi A, Palvimo JJ, Sariola H, Partanen J, Jänne OA. An adenosine triphosphatase of the sucrose nonfermenting 2 family, androgen receptor-interacting protein 4, is essential for mouse embryonic development and cell proliferation. Molecular Endocrinology (Baltimore, Md.). 21: 1430-42. PMID 17374848 DOI: 10.1210/Me.2007-0052  0.378
2007 Partanen J. FGF signalling pathways in development of the midbrain and anterior hindbrain. Journal of Neurochemistry. 101: 1185-93. PMID 17326764 DOI: 10.1111/J.1471-4159.2007.04463.X  0.411
2007 Blak AA, Naserke T, Saarimäki-Vire J, Peltopuro P, Giraldo-Velasquez M, Vogt Weisenhorn DM, Prakash N, Sendtner M, Partanen J, Wurst W. Fgfr2 and Fgfr3 are not required for patterning and maintenance of the midbrain and anterior hindbrain. Developmental Biology. 303: 231-43. PMID 17150206 DOI: 10.1016/J.Ydbio.2006.11.008  0.428
2006 Jacob AL, Smith C, Partanen J, Ornitz DM. Fibroblast growth factor receptor 1 signaling in the osteo-chondrogenic cell lineage regulates sequential steps of osteoblast maturation. Developmental Biology. 296: 315-28. PMID 16815385 DOI: 10.1016/J.Ydbio.2006.05.031  0.379
2006 Jukkola T, Lahti L, Naserke T, Wurst W, Partanen J. FGF regulated gene-expression and neuronal differentiation in the developing midbrain-hindbrain region. Developmental Biology. 297: 141-57. PMID 16782087 DOI: 10.1016/J.Ydbio.2006.05.002  0.434
2006 Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E, Taipale J. Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell. 124: 47-59. PMID 16413481 DOI: 10.1016/J.Cell.2005.10.042  0.338
2006 Saarimäki-Vire J, Peltopuro P, Blak A, Lahti L, Ornitz D, Wurst W, Partanen J. Redundant functions of Fgfr1, Fgfr2 and Fgfr3 in the development of the mid- and hindbrain International Journal of Developmental Neuroscience. 24: 558-559. DOI: 10.1016/J.Ijdevneu.2006.09.207  0.304
2005 Jukkola T, Trokovic R, Maj P, Lamberg A, Mankoo B, Pachnis V, Savilahti H, Partanen J. Meox1Cre: a mouse line expressing Cre recombinase in somitic mesoderm. Genesis (New York, N.Y. : 2000). 43: 148-53. PMID 16267823 DOI: 10.1002/Gene.20163  0.36
2005 Trokovic N, Trokovic R, Partanen J. Fibroblast growth factor signalling and regional specification of the pharyngeal ectoderm. The International Journal of Developmental Biology. 49: 797-805. PMID 16172976 DOI: 10.1387/Ijdb.051976Nt  0.428
2005 Blak AA, Naserke T, Weisenhorn DM, Prakash N, Partanen J, Wurst W. Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. Developmental Dynamics : An Official Publication of the American Association of Anatomists. 233: 1023-30. PMID 15830353 DOI: 10.1002/Dvdy.20386  0.396
2005 Magnusson PU, Ronca R, Dell'Era P, Carlstedt P, Jakobsson L, Partanen J, Dimberg A, Claesson-Welsh L. Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. Arteriosclerosis, Thrombosis, and Vascular Biology. 25: 944-9. PMID 15774903 DOI: 10.1161/01.Atv.0000163182.73190.F9  0.354
2004 Jukkola T, Sinjushina N, Partanen J. Drapc1 expression during mouse embryonic development. Gene Expression Patterns : Gep. 4: 755-62. PMID 15465500 DOI: 10.1016/J.Modgep.2004.03.006  0.373
2004 Satoh Y, Haraguchi R, Wright TJ, Mansour SL, Partanen J, Hajihosseini MK, Eswarakumar VP, Lonai P, Yamada G. Regulation of external genitalia development by concerted actions of FGF ligands and FGF receptors. Anatomy and Embryology. 208: 479-86. PMID 15340846 DOI: 10.1007/S00429-004-0419-9  0.408
2004 Ohkubo Y, Uchida AO, Shin D, Partanen J, Vaccarino FM. Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 6057-69. PMID 15240797 DOI: 10.1523/Jneurosci.1140-04.2004  0.427
2003 Trokovic R, Trokovic N, Hernesniemi S, Pirvola U, Vogt Weisenhorn DM, Rossant J, McMahon AP, Wurst W, Partanen J. FGFR1 is independently required in both developing mid- and hindbrain for sustained response to isthmic signals. The Embo Journal. 22: 1811-23. PMID 12682014 DOI: 10.1093/Emboj/Cdg169  0.416
2003 Hébert JM, Lin M, Partanen J, Rossant J, McConnell SK. FGF signaling through FGFR1 is required for olfactory bulb morphogenesis. Development (Cambridge, England). 130: 1101-11. PMID 12571102 DOI: 10.1242/Dev.00334  0.384
2003 Trokovic N, Trokovic R, Mai P, Partanen J. Fgfr1 regulates patterning of the pharyngeal region. Genes & Development. 17: 141-53. PMID 12514106 DOI: 10.1101/Gad.250703  0.373
2002 Pirvola U, Ylikoski J, Trokovic R, Hébert JM, McConnell SK, Partanen J. FGFR1 is required for the development of the auditory sensory epithelium. Neuron. 35: 671-80. PMID 12194867 DOI: 10.1016/S0896-6273(02)00824-3  0.336
1998 Partanen J, Schwartz L, Rossant J. Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos Genes & Development. 12: 2332-2344. PMID 9694798 DOI: 10.1101/Gad.12.15.2332  0.359
1995 Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells Embo Journal. 14: 5884-5891. PMID 8846781 DOI: 10.1002/J.1460-2075.1995.Tb00276.X  0.334
1993 Partanen J, Vainikka S, Alitalo K. Structural and functional specificity of FGF receptors. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 340: 297-303. PMID 8103932 DOI: 10.1098/Rstb.1993.0071  0.364
1992 Korhonen J, Partanen J, Eerola E, Vainikka S, Ilvesmäki V, Voutilainen R, Julkunen M, Mäkelä T, Alitalo K. Novel human FGF receptors with distinct expression patterns. Annals of the New York Academy of Sciences. 638: 403-5. PMID 1664691 DOI: 10.1111/J.1749-6632.1991.Tb49053.X  0.326
1992 Armstrong E, Partanen J, Cannizzaro L, Huebner K, Alitalo K. Localization of the fibroblast growth factor receptor-4 gene to chromosome region 5q33-qter. Genes, Chromosomes & Cancer. 4: 94-8. PMID 1377018 DOI: 10.1002/Gcc.2870040116  0.307
1992 Partanen J, Vainikka S, Korhonen J, Armstrong E, Alitalo K. Diverse receptors for fibroblast growth factors. Progress in Growth Factor Research. 4: 69-83. PMID 1325208 DOI: 10.1016/0955-2235(92)90005-3  0.373
1992 Korhonen J, Partanen J, Eerola E, Vainikka S, Alitalo R, Mäkelä TP, Sandberg M, Hirvonen H, Alitalo K. Five FGF receptors with distinct expression patterns. Exs. 61: 91-100. PMID 1319781 DOI: 10.1007/978-3-0348-7001-6_16  0.369
1992 Lehtola L, Partanen J, Sistonen L, Korhonen J, Wärri A, Härkönen P, Clarke R, Alitalo K. Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. International Journal of Cancer. 50: 598-603. PMID 1311287 DOI: 10.1002/Ijc.2910500419  0.352
1992 Korhonen J, Partanen J, Alitalo K. Expression of FGFR-4 mRNA in developing mouse tissues. The International Journal of Developmental Biology. 36: 323-329. DOI: 10.1387/Ijdb.1326315  0.339
1992 Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization Blood. 80: 2548-2555. DOI: 10.1182/Blood.V80.10.2548.Bloodjournal80102548  0.355
1991 Partanen J, Mäkelä TP, Alitalo R, Lehväslaiho H, Alitalo K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proceedings of the National Academy of Sciences of the United States of America. 87: 8913-7. PMID 2247464 DOI: 10.1073/Pnas.87.22.8913  0.351
1991 Partanen J, Mäkelä T, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, Alitalo K. FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. The Embo Journal. 10: 1347-1354. DOI: 10.1002/J.1460-2075.1991.Tb07654.X  0.377
1990 Lehväslaiho H, Sistonen L, diRenzo F, Partanen J, Comoglio P, Hölttä E, Alitalo K. Regulation by EGF is maintained in an overexpressed chimeric EGFR/neu receptor tyrosine kinase. Journal of Cellular Biochemistry. 42: 123-33. PMID 1969420 DOI: 10.1002/Jcb.240420303  0.344
1990 Alitalo R, Partanen J, Pertovaara L, Holtta E, Sistonen L, Andersson L, Alitalo K. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells Blood. 75: 1974-1982. DOI: 10.1182/Blood.V75.10.1974.1974  0.325
Low-probability matches (unlikely to be authored by this person)
1992 Mäkelä TP, Partanen J, Schwab M, Alitalo K. Plasmid pLTRpoly: a versatile high-efficiency mammalian expression vector. Gene. 118: 293-4. PMID 1511904 DOI: 10.1016/0378-1119(92)90203-2  0.298
2011 Chilov D, Sinjushina N, Rita H, Taketo MM, Mäkelä TP, Partanen J. Phosphorylated β-catenin localizes to centrosomes of neuronal progenitors and is required for cell polarity and neurogenesis in developing midbrain. Developmental Biology. 357: 259-68. PMID 21736876 DOI: 10.1016/J.Ydbio.2011.06.029  0.297
2020 Morello F, Voikar V, Parkkinen P, Panhelainen A, Rosenholm M, Makkonen A, Rantamäki T, Piepponen P, Aitta-Aho T, Partanen J. ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem. Translational Psychiatry. 10: 357. PMID 33087695 DOI: 10.1038/s41398-020-01033-8  0.294
1990 PARTANEN J, MAKELA T, ALITALO R, LEHVASLAIHO H, ALITALO K. Novel tyrosine kinases expressed in the K562 human leukemia cells Cell Biology International Reports. 14: 67. DOI: 10.1016/0309-1651(90)90376-A  0.293
2005 Trokovic R, Jukkola T, Saarimäki J, Peltopuro P, Naserke T, Weisenhorn DM, Trokovic N, Wurst W, Partanen J. Fgfr1-dependent boundary cells between developing mid- and hindbrain. Developmental Biology. 278: 428-39. PMID 15680361 DOI: 10.1016/J.Ydbio.2004.11.024  0.288
2016 Akawi N, Ben-Salem S, Lahti L, Partanen J, Ali BR, Al-Gazali L. A recessive syndrome of intellectual disability, moderate overgrowth, and renal dysplasia predisposing to Wilms tumor is caused by a mutation in FIBP gene. American Journal of Medical Genetics. Part A. PMID 27183861 DOI: 10.1002/Ajmg.A.37741  0.288
2018 Balboa D, Saarimäki-Vire J, Borshagovski D, Survila M, Lindholm P, Galli E, Eurola S, Ustinov J, Grym H, Huopio H, Partanen J, Wartiovaara K, Otonkoski T. Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes. Elife. 7. PMID 30412052 DOI: 10.7554/Elife.38519  0.287
2010 Saarimaki-Vire J, Turakainen H, Alitalo A, Sinjushina N, Savilahti H, Partanen J. Boundary cell specific adhesion molecule, PB–cadherin, is not required for maintenance the midbrain-hindbrain border International Journal of Developmental Neuroscience. 28: 665. DOI: 10.1016/J.Ijdevneu.2010.07.069  0.28
2002 Vartiainen MK, Mustonen T, Mattila PK, Ojala PJ, Thesleff I, Partanen J, Lappalainen P. The three mouse actin-depolymerizing factor/cofilins evolved to fulfill cell-type-specific requirements for actin dynamics. Molecular Biology of the Cell. 13: 183-94. PMID 11809832 DOI: 10.1091/Mbc.01-07-0331  0.279
2006 Zhao H, Yang Y, Partanen J, Ciruna BG, Rossant J, Robinson ML. Fibroblast growth factor receptor 1 (Fgfr1) is not essential for lens fiber differentiation in mice. Molecular Vision. 12: 15-25. PMID 16446698  0.277
2007 Moza M, Mologni L, Trokovic R, Faulkner G, Partanen J, Carpén O. Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice. Molecular and Cellular Biology. 27: 244-52. PMID 17074808 DOI: 10.1128/Mcb.00561-06  0.273
1990 ALITALO R, PARTANEN J, HOLTTA E, ALITALO K. Increased EPA/TIMP and characterize TPA-induced megakaryoblastic differentiation of K562 cells Cell Biology International Reports. 14: 56. DOI: 10.1016/0309-1651(90)90329-W  0.273
1991 Armstrong E, Hästbacka J, Partanen J, Huebner K, Alitalo K. RFLPs in the fibroblast growth factor receptor-4 locus (FGFR4) in 5q33-qter. Nucleic Acids Research. 19: 5096. PMID 1681501 DOI: 10.1093/Nar/19.18.5096-A  0.271
2004 Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P, Chambon P, Cox R, Davidson D, Davies K, Duboule D, ... ... Partanen J, et al. The European dimension for the mouse genome mutagenesis program. Nature Genetics. 36: 925-7. PMID 15340424 DOI: 10.1038/Ng0904-925  0.268
2004 Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nature Immunology. 5: 74-80. PMID 14634646 DOI: 10.1038/Ni1013  0.262
1992 Bergman M, Mustelin T, Oetken C, Partanen J, Flint N, Amrein K, Autero M, Burn P, Alitalo K. The human p50csk tyrosine kinase phosphorylates p56lck at Tyr-505 and down regulates its catalytic activity. The Embo Journal. 11: 2919-2924. DOI: 10.1002/J.1460-2075.1992.Tb05361.X  0.257
2009 Turakainen H, Saarimäki-Vire J, Sinjushina N, Partanen J, Savilahti H. Transposition-based method for the rapid generation of gene-targeting vectors to produce Cre/Flp-modifiable conditional knock-out mice. Plos One. 4: e4341. PMID 19194496 DOI: 10.1371/Journal.Pone.0004341  0.256
2005 Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J, Ornitz DM. Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Developmental Cell. 8: 85-95. PMID 15621532 DOI: 10.1016/J.Devcel.2004.12.002  0.25
2021 Englund J, Haikonen J, Shteinikov V, Amarilla SP, Atanasova T, Shintyapina A, Ryazantseva M, Partanen J, Voikar V, Lauri SE. Downregulation of kainate receptors regulating GABAergic transmission in amygdala after early life stress is associated with anxiety-like behavior in rodents. Translational Psychiatry. 11: 538. PMID 34663781 DOI: 10.1038/s41398-021-01654-7  0.247
1992 Partanen J, Armstrong E, Mäkelä TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Molecular and Cellular Biology. 12: 1698-707. PMID 1312667 DOI: 10.1128/Mcb.12.4.1698  0.247
2009 Herrmann D, Cheng S, Driller K, Partanen J, Neubüser A. 09-P054 Analysis of facial and palatal defects in Fgfr1 mutant mice Mechanisms of Development. 126. DOI: 10.1016/J.Mod.2009.06.384  0.245
2018 Balboa D, Saarimäki-Vire J, Borshagovski D, Survila M, Lindholm P, Galli E, Eurola S, Ustinov J, Grym H, Huopio H, Partanen J, Wartiovaara K, Otonkoski T. Author response: Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetes Elife. DOI: 10.7554/Elife.38519.031  0.233
2021 DeSalvo J, Ban Y, Li L, Sun X, Jiang Z, Kerr DA, Khanlari M, Boulina M, Capecchi MR, Partanen JM, Chen L, Kondo T, Ornitz DM, Trent JC, Eid JE. ETV4/5 drive synovial sarcoma through control of the cell cycle and the DUX4 embryonic pathway. The Journal of Clinical Investigation. PMID 33983905 DOI: 10.1172/JCI141908  0.226
1993 Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyrhönen S, Lehtovirta P, Nevanlinna H. Amplification of fgfr4 gene in human breast and gynecological cancers International Journal of Cancer. 54: 378-382. PMID 8099571 DOI: 10.1002/Ijc.2910540305  0.225
2020 Mennesson M, Orav E, Gigliotta A, Kulesskaya N, Saarnio S, Kirjavainen A, Kesaf S, Winkel F, Llach Pou M, Umemori J, Voikar V, Risbrough V, Partanen J, Castrén E, Lauri SE, et al. Kainate Receptor Auxiliary Subunit NETO2-Related Cued Fear Conditioning Impairments Associate with Defects in Amygdala Development and Excitability. Eneuro. 7. PMID 32788298 DOI: 10.1523/ENEURO.0541-19.2020  0.224
2020 Ryazantseva M, Englund J, Shintyapina A, Huupponen J, Shteinikov V, Pitkänen A, Partanen JM, Lauri SE. Kainate receptors regulate development of glutamatergic synaptic circuitry in the rodent amygdala. Elife. 9. PMID 32202495 DOI: 10.7554/eLife.52798  0.204
2023 Saarikettu J, Lehmusvaara S, Pesu M, Junttila I, Partanen J, Sipilä P, Poutanen M, Yang J, Haikarainen T, Silvennoinen O. The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. Faseb Bioadvances. 5: 183-198. PMID 37151849 DOI: 10.1096/fba.2022-00115  0.192
1972 Partanen J. On The Relevance Of Twin Studies Annals of the New York Academy of Sciences. 197: 114-116. PMID 4504584 DOI: 10.1111/J.1749-6632.1972.Tb28129.X  0.183
2017 Orav E, Atanasova T, Shintyapina A, Kesaf S, Kokko M, Partanen J, Taira T, Lauri SE. NETO1 Guides Development of Glutamatergic Connectivity in the Hippocampus by Regulating Axonal Kainate Receptors. Eneuro. 4. PMID 28680963 DOI: 10.1523/ENEURO.0048-17.2017  0.177
2004 Partanen J. Recensioner Nordic Studies On Alcohol and Drugs. 21: 437-439. DOI: 10.1177/145507250402100604  0.12
2010 Böhm F, Speicher T, Hellerbrand C, Dickson C, Partanen JM, Ornitz DM, Werner S. FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice. Gastroenterology. 139: 1385-96. PMID 20603121 DOI: 10.1053/J.Gastro.2010.06.069  0.12
2006 Kinnunen T, Taivainen A, Partanen J, Immonen A, Saarelainen S, Rytkönen-Nissinen M, Rautiainen J, Virtanen T. The DR4-DQ8 haplotype and a specific T cell receptor Vbeta T cell subset are associated with absence of allergy to Can f 1. Clinical and Experimental Allergy : Journal of the British Society For Allergy and Clinical Immunology. 35: 797-803. PMID 15969672 DOI: 10.1111/j.1365-2222.2005.02247.x  0.11
2018 Zega K, Jovanovic VM, Vitic Z, Niedzielska M, Knaapi L, Jukic MM, Partanen J, Friedel RH, Lang R, Brodski C. Corrigendum: Dusp16 Deficiency Causes Congenital Obstructive Hydrocephalus and Brain Overgrowth by Expansion of the Neural Progenitor Pool. Frontiers in Molecular Neuroscience. 11: 29. PMID 29417959 DOI: 10.3389/fnmol.2018.00029  0.092
1998 Partanen J, Metso L. Cannabis use in Finland in the 1990s: An Overview of Adult Populations Survey Results Nordic Studies On Alcohol and Drugs. 15: 34-40. DOI: 10.1177/145507259801500102  0.044
1988 Partanen J, Heikkilä J, Pellinen T, Nieminen MS. Effect of digoxin on the heart in normal subjects: influence of isometric exercise and autonomic blockade: a noninvasive study. British Journal of Clinical Pharmacology. 25: 331-40. PMID 3358896 DOI: 10.1111/J.1365-2125.1988.TB03311.X  0.042
1996 Kekomäki S, Partanen J, Kekomäki R. Platelet alloantigens HPA-1, -2, -3, -5 and -6b in Finns. Transfusion Medicine (Oxford, England). 5: 193-8. PMID 8593523 DOI: 10.1111/j.1365-3148.1995.tb00227.x  0.039
1967 PARTANEN J, BRUUN K, MARKKANEN T. Inheritance of Drinkingg Beravior The American Journal of the Medical Sciences. 254: 383. DOI: 10.1097/00000441-196709000-00026  0.036
2016 Akawi N, Ben-Salem S, Lahti L, Partanen J, Ali BR, Al-Gazali L. Cover Image, Volume 170A, Number 8, August 2016. American Journal of Medical Genetics. Part A. 170: i. PMID 27410198 DOI: 10.1002/ajmg.a.37834  0.032
1988 Partanen J, Nieminen MS, Lehto H. Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study. Clinical Cardiology. 11: 15-22. PMID 3349658 DOI: 10.1002/CLC.4960110112  0.031
1991 Partanen J, Nieminen MS, Krogerus L, Lautenschlager I, Geagea A, Aarnio P, Mattila S. Cytomegalovirus myocarditis in transplanted heart verified by endomyocardial biopsy. Clinical Cardiology. 14: 847-9. PMID 1659506 DOI: 10.1002/CLC.4960141012  0.031
2011 Niinimäki TT, Murray DW, Partanen J, Pajala A, Leppilahti JI. Unicompartmental knee arthroplasties implanted for osteoarthritis with partial loss of joint space have high re-operation rates. The Knee. 18: 432-5. PMID 21093269 DOI: 10.1016/j.knee.2010.08.004  0.03
1997 Partanen J, Jalava KM, Neuvonen PJ. Itraconazole increases serum digoxin concentration. Pharmacology & Toxicology. 79: 274-6. PMID 8936563 DOI: 10.1111/J.1600-0773.1996.TB00273.X  0.03
2004 Partanen J, Jalovaara P. Functional comparison between uncemented Austin-Moore hemiarthroplasty and osteosynthesis with three screws in displaced femoral neck fractures--a matched-pair study of 168 patients. International Orthopaedics. 28: 28-31. PMID 14586571 DOI: 10.1007/s00264-003-0517-y  0.028
2002 Partanen J, Heikkinen J, Jämsä T, Jalovaara P. Characteristics of lifetime factors, bone metabolism, and bone mineral density in patients with hip fracture. Journal of Bone and Mineral Metabolism. 20: 367-75. PMID 12434165 DOI: 10.1007/s007740200053  0.026
2004 Pulkkinen P, Partanen J, Jalovaara P, Jämsä T. Combination of bone mineral density and upper femur geometry improves the prediction of hip fracture. Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation For Osteoporosis and the National Osteoporosis Foundation of the Usa. 15: 274-80. PMID 14760516 DOI: 10.1007/s00198-003-1556-3  0.025
2004 Sipilä J, Hyvönen P, Partanen J, Ristiniemi J, Jalovaara P. Early revision after hemiarthroplasty and osteosynthesis of cervical hip fracture: short-term function mortality unchanged in 102 patients. Acta Orthopaedica Scandinavica. 75: 402-7. PMID 15370582 DOI: 10.1080/00016470410001150-1  0.025
1995 Partanen J. Våta Tripper: Bruket av Narkotika och Lugnande Medel i Finland Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 12: 21-33. DOI: 10.1177/145507259501200116  0.024
2002 Partanen J, Saarenpää I, Heikkinen T, Wingstrand H, Thorngren KG, Jalovaara P. Functional outcome after displaced femoral neck fractures treated with osteosynthesis or hemiarthroplasty: a matched-pair study of 714 patients. Acta Orthopaedica Scandinavica. 73: 496-501. PMID 12440490  0.024
1997 Partanen J, Verkkala KA, Karhunen PJ, Kauppila R, Nieminen MS. Profuse mediastinal haemorrhage due to mediastinitis after sternotomy. Report of three cases and review of the literature. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 30: 167-73. PMID 8976038 DOI: 10.3109/14017439609107263  0.022
1992 Partanen J, Kupari M, Heikkilä J, Keto P. Left ventricular aneurysm associated with apical hypertrophic cardiomyopathy. Clinical Cardiology. 14: 936-9. PMID 1764832 DOI: 10.1002/CLC.4960141115  0.021
1996 Partanen J. Why alcohol and drug research remains a marginal activity Addiction. 91: 225-226. DOI: 10.1111/J.1360-0443.1996.TB03180.X  0.021
2002 Heikkinen T, Wingstrand H, Partanen J, Thorngren KG, Jalovaara P. Hemiarthroplasty or osteosynthesis in cervical hip fractures: matched-pair analysis in 892 patients. Archives of Orthopaedic and Trauma Surgery. 122: 143-7. PMID 11927995 DOI: 10.1007/s004020100325  0.02
1998 Partanen J. Merchant, priest and humble engineer: Observations from Rotterdam's drug scenes Nordic Studies On Alcohol and Drugs. 15: 52-67. DOI: 10.1177/145507259801501S05  0.02
1984 Pellinen TJ, Verkkala KA, Partanen JH, Maamies TJ, Valtonen VV. False aneurysm of the right ventricle due to endocarditis after heart surgery. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 18: 53-5. PMID 6719074 DOI: 10.3109/14017438409099384  0.019
1997 Partanen J, Tierala I. Images in cardiovascular medicine. Huge dilatation of pulmonary arteries due To ventricular septal defect with the Eisenmenger syndrome. Circulation. 94: 3014-5. PMID 8941151 DOI: 10.1161/01.CIR.94.11.3014  0.017
1997 Partanen J. The merchant, the priest, and the humble engineer. Observations on the Rotterdam drug scene Nordic Studies On Alcohol and Drugs. 14: 167-183. DOI: 10.1177/145507259701400307  0.016
1994 Partanen J. Book Review: The Italian alcohol culture in full portrait Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 11: 68-69. DOI: 10.1177/145507259401101S09  0.016
2006 Partanen J. Conversation with Juha Partanen. Addiction (Abingdon, England). 101: 1399-407. PMID 16968340 DOI: 10.1111/j.1360-0443.2006.01482.x  0.014
1991 Partanen J. Den tredje jakten Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 8: 289-293. DOI: 10.1177/145507259100800507  0.014
1993 Partanen J, Väisälä J. Extension of bilipschitz maps of compact polyhedra. Mathematica Scandinavica. 72: 235. DOI: 10.7146/MATH.SCAND.A-12447  0.014
2006 Partanen J. Spectacles of Sociability and Drunkenness: On Alcohol and Drinking in Japan Contemporary Drug Problems. 33: 177-204. DOI: 10.1177/009145090603300202  0.01
1996 Partanen J. A Global view on Alcohol and Drinking Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 13: 1-3. DOI: 10.1177/145507259601301S01  0.01
1996 Partanen J. Book Review: Antropolog i den Egna Kulturen Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 13: 308-309. DOI: 10.1177/1455072596013005-603  0.01
1995 Partanen J, Kupari M, Eränen J, Kouri J. Intermittent mitral regurgitation and pulmonary edema after aortic valve replacement. International Journal of Cardiology. 49: 131-4. PMID 7628884 DOI: 10.1016/0167-5273(95)02293-6  0.01
1995 Partanen J. Izakaya – Kvarterskrogar På Japanskt Vis Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 12: 161-163. DOI: 10.1177/145507259501200306  0.01
1993 Partanen J. Book Review: Narkotikafrågan i Finland Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 10: 51-52. DOI: 10.1177/145507259301000116  0.01
1992 Partanen J. Book Review Nordisk Alkoholtisdkrift (Nordic Alcohol Studies). 9: 345-345. DOI: 10.1177/145507259200900609  0.01
1991 Partanen J. Economic evaluation of cholesterol lowering. The American Journal of Cardiology. 68: 1120. PMID 1927937 DOI: 10.1016/0002-9149(91)90514-L  0.01
1988 Partanen J. Effect of Intravenous Digoxin on the Heart at Rest and During Isometric Exercise Journal of Cardiovascular Pharmacology. 11: 159-166. DOI: 10.1097/00005344-198802000-00006  0.01
1977 Partanen J. Review Symposium : Sociology in Time of Crisis Acta Sociologica. 20: 305-311. DOI: 10.1177/000169937702000307  0.01
Hide low-probability matches.